Literature DB >> 22314427

Futility and rationing in liver retransplantation: when and how can we say no?

Scott W Biggins1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22314427      PMCID： PMC3820294          DOI： 10.1016/j.jhep.2011.11.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  28 in total

Review 1.  Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations.

Authors:  Scott W Biggins; Athena Beldecos; John M Rabkin; Hugo R Rosen
Journal:  Liver Transpl       Date:  2002-04       Impact factor: 5.799

2.  Does MELD work for relisted candidates?

Authors:  Erick Edwards; Ann Harper
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

Review 3.  Futility and rationing.

Authors:  N S Jecker; L J Schneiderman
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

4.  The efficacy and equity of retransplantation: an experimental survey of public attitudes.

Authors:  P A Ubel; G Loewenstein
Journal:  Health Policy       Date:  1995-11       Impact factor: 2.980

5.  Futility, autonomy, and cost in end-of-life care.

Authors:  Mary Ann Baily
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

6.  Rationing failure. The ethical lessons of the retransplantation of scarce vital organs.

Authors:  P A Ubel; R M Arnold; A L Caplan
Journal:  JAMA       Date:  1993-11-24       Impact factor: 56.272

7.  Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage.

Authors:  J Neuberger; O James
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

Review 8.  Medical futility: its meaning and ethical implications.

Authors:  L J Schneiderman; N S Jecker; A R Jonsen
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

9.  Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.

Authors:  Kim M Olthoff; Robert S Brown; Francis L Delmonico; Richard B Freeman; Sue V McDiarmid; Robert M Merion; J Michael Millis; John P Roberts; Abraham Shaked; Russell H Wiesner; Michael R Lucey
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

10.  Validation and refinement of survival models for liver retransplantation.

Authors:  Hugo R Rosen; Martin Prieto; Teresa Casanovas-Taltavull; Valentin Cuervas-Mons; Olaf Guckelberger; Paolo Muiesan; Russell W Strong; Wolf O Bechstein; John O'grady; Atif Zaman; Benjamin Chan; Joaquin Berenguer; Roger Williams; Nigel Heaton; Peter Neuhaus
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425
View more
  11 in total

1.  Risk Factors and Center-Level Variation in Hepatocellular Carcinoma Under-Staging for Liver Transplantation.

Authors:  Nadim Mahmud; Maarouf A Hoteit; David S Goldberg
Journal:  Liver Transpl       Date:  2020-08       Impact factor: 5.799

Review 2.  Palliative care for patients with end-stage liver disease.

Authors:  Anne M Larson
Journal:  Curr Gastroenterol Rep       Date:  2015-05

Review 3.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10

4.  Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

Authors:  Alice Tung Wan Song; Rodolphe Sobesky; Carmen Vinaixa; Jérôme Dumortier; Sylvie Radenne; François Durand; Yvon Calmus; Géraldine Rousseau; Marianne Latournerie; Cyrille Feray; Valérie Delvart; Bruno Roche; Stéphanie Haim-Boukobza; Anne-Marie Roque-Afonso; Denis Castaing; Edson Abdala; Luiz Augusto Carneiro D'Albuquerque; Jean-Charles Duclos-Vallée; Marina Berenguer; Didier Samuel
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

5.  Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.

Authors:  S W Biggins; J Gralla; J L Dodge; K M Bambha; S Tong; A E Barón; J Inadomi; N Terrault; H R Rosen
Journal:  Am J Transplant       Date:  2014-09-19       Impact factor: 8.086

6.  Differences in Posttransplant Hepatocellular Carcinoma Recurrence by Etiology of Liver Disease.

Authors:  Nadim Mahmud; Abraham Shaked; Kim M Olthoff; David S Goldberg
Journal:  Liver Transpl       Date:  2019-03       Impact factor: 5.799

7.  Defining a Willingness-to-transplant Threshold in an Era of Organ Scarcity: Simultaneous Liver-kidney Transplant as a Case Example.

Authors:  Xingxing S Cheng; Jeremy Goldhaber-Fiebert; Jane C Tan; Glenn M Chertow; W Ray Kim; Anji E Wall
Journal:  Transplantation       Date:  2020-02       Impact factor: 5.385

8.  Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort.

Authors:  Alyssa K Mezochow; Peter L Abt; Therese Bittermann
Journal:  Transplantation       Date:  2021-08-01       Impact factor: 5.385

9.  BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION.

Authors:  Júlio Cezar Uili Coelho; Lucas de Oliveira Leite; Antonio Molena; Alexandre Coutinho Teixeira de Freitas; Jorge Eduardo Fouto Matias
Journal:  Arq Bras Cir Dig       Date:  2017 Apr-Jun

10.  Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation.

Authors:  Mohammad A B Al-Freah; Carl Moran; Matthew R Foxton; Kosh Agarwal; Julia A Wendon; Nigel D Heaton; Michael A Heneghan
Journal:  World J Hepatol       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.